A new Macquarie University study suggests that instead of relying on the 'bible' of mental health diagnosis, we need a data-driven approach based on the ways symptoms naturally co-occur in real ...

Major depressive disorder (MDD) is a chronic and recurrent mental condition leading to huge impacts on direct and indirect personal and public medical costs. To overcome such a serious mental ...

This study highlights the efficacy of home-based tDCS in treating major depressive disorder, with significant improvements in ...

Johnson & Johnson (NYSE: JNJ) announced today that 23 abstracts featuring new real-world and clinical trial data from across its neuropsychiatry portfolio and pipeline will be presented at the annual ...

Increasing prevalence of anxiety and depression, coupled with innovation in pharmaceutical treatments and growing demand for mental health solutions, fuels growth in the anxiety disorders and ...

Medicare Advantage (MA) insurers, namely industry titans UnitedHealth Group and Humana, could be using health risk ...

“It’s normal to be frustrated and even need to put the baby down sometimes.” Postpartum depression symptoms may be more likely ― or more severe ― in some individuals. These are some factors: History ...

The DWP's decision to send work coaches into mental health hospitals to push vulnerable patients off benefits and into work ...

We never left a feature untouched in our reviews of the best PDF editor. From OCR and eSignatures to cloud storage services, we’ve tested them all – so we know what makes the best choice for ...

A device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new study by researchers at UTHealth Houston; the ...

We list the best PDF merger tools, to make it simple and easy to combine documents together into one file. We put the top tools to the test to see which makes for the best workflow. The easiest ...

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO® (Respiratory Syncytial Virus Vaccine), the company's bivalent RSV prefusion F (RSVpreF) vaccine, for ...